Clinical Trials Logo

Clinical Trial Summary

This trial wants to address high unmet need for postpartum family planning (PPFP) in Rwanda. A previous pilot study tested the intervention (informed by formative work with couples/clients, clinic providers, champions, and community health workers), which significantly increased the use of PPFP in government clinics. This study now proposes to use an implementation science framework to test the hypothesis that the proposed PPFP intervention is adaptable to large-scale implementation, cost-effective, and sustainable. This PPFP could dramatically reduce unintended pregnancy and abortion and improve birth spacing and maternal and newborn health.


Clinical Trial Description

In 2017-2018, the study team worked closely with the Rwanda Ministry of Health (MOH) to develop and pilot test a theory-based, multi-level intervention targeting postpartum family planning (PPFP) supply and demand in 4 government health facilities in Kigali, the capital. This innovative PPFP intervention was informed by clients, clinic providers, champions, and Community Health Workers. Long-acting reversible contraceptives (LARC), the intrauterine device (PPIUD) and implant, are fundamental to PPFP programs. LARCs are highly effective and are the only reversible methods that may be safely used in early postpartum period by breastfeeding women. During the pilot, LARC uptake among postpartum women increased significantly (172% for PP implant, 2,687% for PPIUD), PPFP feasibility and acceptability were high among providers and clients, and side-effects were rare. The study team now proposes to use an implementation science framework to evaluate the effectiveness of different PPFP demand creation strategies and test the hypothesis that our PPFP intervention is adaptable to large-scale implementation, cost-effective, and sustainable. In a Type 2 effectiveness-implementation hybrid study, we will evaluate facility organizational readiness prior to implementing the PPFP intervention in a clinic randomized trial in 10 high-volume health facilities in Kigali, Rwanda (Aim 1). Adaptability and sustainability within government facilities is a critical aspect of the proposal, and the MOH and other local stakeholders will be engaged from the outset. It is expected that this project will deliver PPFP counseling to over 21,000 women/couples during the project period. They will then evaluate the PPFP intervention effectiveness and implementation processes using RE-AIM (Aim 2). The team hypothesizes that the PPFP intervention will significantly increase the number of stakeholders engaged, PPFP providers and promoters, couples/clients receiving information about PPFP (reach), and LARC uptake (effectiveness) comparing intervention versus standard of care. It is expected that PPFP client satisfaction will be high and side-effects will be rare. The independent effectiveness of each demand creation strategy on LARC uptake will be estimated. Assessment of measures of PPFP intervention adoption, implementation, and maintenance at the patient-, provider- and stakeholder-level to assess PPFP intervention sustainability will be completed by the study team. Finally, this project will evaluate PPFP intervention cost-effectiveness and develop a national costed implementation plan to guide Rwandan MOH decision-making for nationwide roll-out of PPFP services (Aim 3). This trial hypothesizes that the PPFP intervention will be cost-saving relative to standard of care. This intervention represents an important contribution to the Rwanda Family Planning 2020 goals and the MOH are enthusiastic to see our successful pilot efforts expanded to a larger number of facilities for greater and sustained impact. The new PPFP implementation model is designed to be replicable and expandable to other countries in the region which similarly have high unmet need for PPFP. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05056545
Study type Interventional
Source Emory University
Contact Kristin Wall, PhD
Phone 404-727-9088
Email kmwall@emory.edu
Status Recruiting
Phase N/A
Start date August 1, 2022
Completion date March 31, 2026

See also
  Status Clinical Trial Phase
Completed NCT00928538 - Nurse Family Partnership (NFP) Contraceptive Study Phase 4
Not yet recruiting NCT04521517 - Effect of Pamphlet Supported Counseling During Child Immunization on the Initiation of Post-partum Family Planning N/A
Completed NCT03660514 - Jovenes Sanos: Preventing IPV and RC N/A
Completed NCT02866643 - Labor and Delivery Implant Insertion: A Randomized Controlled Trial Phase 3
Completed NCT05503992 - Evaluating the Efficacy of Using a Digital Consumption Management Tool for Family Planning in Zambia N/A
Recruiting NCT04558229 - RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users Phase 4
Completed NCT03973593 - Evaluation of Dynamics of Contraceptive Use, Discontinuation and Method Switching in Migori and Kitui Counties, Kenya
Completed NCT02711358 - Indomethacin Use in Pain Relief During Intrauterine Device Insertion Phase 4
Completed NCT02714231 - Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion Phase 4
Completed NCT01593943 - Gender Equity-Focused, Male-Centered Family Planning for Rural India Phase 3
Completed NCT03106727 - Evaluating the Impact of a Community Health Worker Program in Neno, Malawi N/A
Completed NCT01288274 - Community Based Distribution of Injectable Contraceptives in Tigray, Ethiopia N/A
Completed NCT03534401 - Addressing Reproductive Coercion in HEalth Settings - Kenya N/A
Completed NCT03576157 - Kilkari Impact Evaluation N/A
Not yet recruiting NCT04970420 - Health Responsibility and Family Planning ın Immigrant Women (Ahıska Turks). N/A
Completed NCT01894126 - Mobile Phone Messaging to Improve Women's and Children's Health (Mobile WACh) in Kenya N/A
Completed NCT03490617 - Misoprostol Prior to IUD Insertion in Nullipara Phase 3
Completed NCT06320964 - The TARANG Intervention N/A
Completed NCT03135288 - Cell-phone Assisted Postpartum Counseling on the Use of Long-acting Reversible Contraceptives N/A
Completed NCT02633631 - Contraceptive Choice Center